2023 PSS Guide
Coherus BioSciences’ Coherus Solutions offers comprehensive reimbursement and support services for patients receiving treatment with Udenyca (pegfilgrastim-cbqv) who are unable to afford this medication. Read More ›
Daiichi-Sankyo’s Access Central offers comprehensive reimbursement and support services for patients who are prescribed Injectafer or Turalio. Read More ›
Daiichi-Sankyo and AstraZeneca offer the Enhertu4U support program to provide information and assistance to patients who have been prescribed Enhertu. Read More ›
Eisai offers drug-specific reimbursement assistance to patients taking Halaven or Lenvima. Read More ›
EMD Serono and Pfizer provide the CoverOne support services, a set of patient assistance programs that offer reimbursement services, copay assistance, and billing and coding resources for patients who are prescribed Bavencio (avelumab), a fully human PD-L1 monoclonal antibody. In addition, the EMD Serono Oncology Navigation Center (ONC) is a patient access and reimbursement support program available to eligible patients who are prescribed Tepmetko (tepotinib). Read More ›
Epizyme offers the EpizymeNOW patient support program for patients who have been prescribed Tazverik. Read More ›
Exelixis Access Services (EASE) includes programs designed to support patients who are prescribed Exelixis oncology drugs Cabometyx or Cometriq. Read More ›
G1 Therapeutics offers the G1 to One patient support program to support patients who are prescribed Cosela. Read More ›
Genentech provides support to help facilitate access to Genentech Oncology medicines for eligible patients. Read More ›
Gilead Sciences offers the Trodelvy Access Support and the Zydelig AccessConnect programs for patients who are prescribed Trodelvy or Zydelig. Read More ›
GSK offers the Together with GSK Oncology program for patients who are prescribed a GSK oncology drug. Read More ›
Helsinn Therapeutics offers the Helsinn Cares program that supports access, reimbursement, and assistance for patients who are prescribed a Helsinn Therapeutics oncology medication. Read More ›
Immunocore offers the KIMMTRAK CONNECT program to deliver customized support for patients who have been prescribed Kimmtrak. Read More ›
ImmunoGen offers Elahere Support Services to support patients who have been prescribed Elahere. Read More ›
Incyte offers IncyteCARES (Connecting to Access, Reimbursement, Education, and Support) to support patients who have been prescribed Jakafi or Pemazyre. Read More ›